Clinical Trial

Liquid BiOpsy, Lung and Colon Cancer in AndaluciA

Study acronym: LOLA-PROJECT
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 30, 2025 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of the LOLA Project is to analyse the impact of adopting xF liquid biopsy panel, in the real world of the Andalusian Health Public System in terms of impact on clinical practice and cost through the assessment of clinical impact, duration of turnaround time (TAT) of xF test vs standard of care and the analysis of resource utilisation.
Trial Details
NCT Number NCT06997458
Lead Sponsor Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Collaborators: Tempus AI
Conditions Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Enrollment 500 participants
Start Date 2024-08-01
Primary Completion 2025-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-30